CVR 36983922Entrepreneurial company (IVS)Forskning og eksperimentel udvikling indenfor bioteknologi (721100)Aarhus NFounded 1 Aug 2015
CVR holds no employment figures for this company.
Compiled by Dandex from the Danish Business Registry (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish Company Data. Connect it once and ask about Nordic Bioindustries IVS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set up DandexGross profit
50.1K
DKK, annual report 2016
Result
+101
DKK, annual report 2016
Equity
1.1K
DKK, annual report 2016
Jomla IVSCVR 38379771, 100% of capital and votes, until 22 Apr 2019
Orla Møller Petersenuntil 6 Feb 2018
No current owner is registered.
CVR 21500445100% of capital and votesnotified 28 Feb 20178 Feb 2017 to 28 Feb 2017
CVR 38379771100% of capital and votes28 Feb 2017 to 22 Apr 2019
Nordic Bioindustries IVS holds no Danish company now.
Danish companies held at 5% or more, from the CVR owner register (ejerregister), and their holdings one level down. Foreign holdings are not in CVR.
CVR 3783177850% to under 66.7% of capital and votes21 Jun 2016 to 1 Jan 2018
CVR 37759147100% of capital and votes26 May 2016 to 19 Jan 2017
Decided by Dandex from CVR and the filed annual reports, not registered by the company.
Fixed rules decide most of these. The auditor's report, the business model, the revenue model and the activity in its own words are read by a calibrated decision model from the report's text and the purpose clause. Each label links to its definition.
CVR lists no current officers for this company.
CVR records founders at incorporation. It does not record whether they are alive or still involved.
The company's own figures, in DKK, from the annual reports filed in XBRL.
| DKK thousands | 2016 |
|---|---|
| Gross profit | 50 |
| Operating profit | 0 |
| Result for the year | 0 |
| Equity | 1 |
| Total assets | 144 |
| Credit metrics (Dandex calculations) | |
| EBITDA / gross profit (EBITDA i procent af bruttofortjenesten)Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. | Pro: EBITDA / gross profit (EBITDA i procent af bruttofortjenesten) is in the Pro plan, see pricingEBITDA as a share of gross profit. |
| Net interest-bearing debt (NIBD, nettorentebærende gæld)Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. | Pro: Net interest-bearing debt (NIBD, nettorentebærende gæld) is in the Pro plan, see pricingInterest-bearing debt less cash and current securities; negative is net cash. |
| Gearing, NIBD / EBITDAPro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. | Pro: Gearing, NIBD / EBITDA is in the Pro plan, see pricingNet interest-bearing debt over EBITDA: the years of earnings the debt takes. |
| Interest coverage (rentedækning)Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. | Pro: Interest coverage (rentedækning) is in the Pro plan, see pricingEBIT over finance expenses: how many times earnings cover the interest. |
| Adjusted equity ratio (justeret soliditetsgrad)Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. | Pro: Adjusted equity ratio (justeret soliditetsgrad) is in the Pro plan, see pricingAdjusted equity as a share of total assets on the same basis. |
| ROIC (afkast af investeret kapital)Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. | Pro: ROIC (afkast af investeret kapital) is in the Pro plan, see pricingReturn on invested capital: EBIT after tax over equity plus net debt. |
| Capex % of sales (investeringer i procent af omsætningen)Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. | Pro: Capex % of sales (investeringer i procent af omsætningen) is in the Pro plan, see pricingCapex as a share of revenue. |
| FCFF / EBITDA (pengestrømskonvertering)Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. | Pro: FCFF / EBITDA (pengestrømskonvertering) is in the Pro plan, see pricingFree cash flow to the firm as a share of EBITDA. |
2016 covers 11 months (1 Aug 2015 to 30 Jun 2016).
Credit metrics are Dandex calculations, not filed values; grey figures are estimates with a note. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may.
Annual report 2016
1 Aug 2015 to 30 Jun 2016, published 20 Feb 2017
No changes since Dandex began following this company. For announcements from before then, see Registrations.
Pro: Signals (signaler) are in the Pro plan, see pricingChanges worth a look, raised from the registry and new annual reports.
New leadership (nyt lederskab), New company (ny virksomhed), Ownership change (ejerskifte), Relocation (flytning), Growth surge (vækstspurt), Headcount decline (nedgang i ansatte), Restructuring (omstrukturering), Industry change (brancheskift), Board change (bestyrelsesændring), Dissolution (ophør), Distress warning (risikoadvarsel), Fund investment (fondsinvestering), Fund exit (fondsexit), Fund board seat (fondsbestyrelsespost).
What Pro holds for Nordic Bioindustries IVS:
Have Pro? Sign in.
Amounts in DKK.
| Date | Change | Cash price | Paid in | Implied value | Capital after |
|---|---|---|---|---|---|
| FoundingCashPaid in 1,000 | None | 1,000 | None | 1,000 |
Source: Erhvervsstyrelsen's announcements, shown where the amounts add up to the registered capital.
Source: CVR, read 16 Nov 2026.
Counts include corrections, and an audit firm that re-registered under a new entity.
Source: CVR, read 16 Nov 2026.
10 registrations, as published by Erhvervsstyrelsen. People's street addresses are cut to postcode and city.
Binavne:
SICE IVS UNDER KONKURS
Saponin Innovation Centre Europe IVS UNDER KONKURS
Konkursbehandlingen afsluttet 28.05.2019, virksomheden opløst
Binavne:
SICE IVS UNDER TVANGSOPLØSNING
Saponin Innovation Centre Europe IVS UNDER TVANGSOPLØSNING
Konkursdekret afsagt 31.05.2018 af Skifteretten i Aarhus
Likvidatorer:
Fratrådte:
Flemming Bastholm, den 31.05.2018.
Revision:
Binavne:
SICE IVS UNDER TVANGSOPLØSNING
Saponin Innovation Centre Europe IVS UNDER TVANGSOPLØSNING
Likvidatorer:
Tiltrådte:
Skifteretten i Aarhus har udnævnt følgende likvidatorer: Flemming Bastholm, 8000 Aarhus C, den 16.03.2018.
Virksomheden tegnes af en likvidator.
Virksomhedens kreditorer opfordres til at anmelde deres krav til likvidator. Krav skal anmeldes senest tre måneder fra dags dato.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Skifteretten i Aarhus den 06.02.2018
Direktion:
Fratrådte:
Orla Møller Petersen, den 06.02.2018.
Vedtægter ændret: 24.08.2017
Nyt navn: Nordic Bioindustries IVS
Nyt binavn: Saponin Innovation Centre Europe IVS
Binavne:
SICE IVS UNDER TVANGSOPLØSNING
Den under 14.01.2017 fremsendte anmodning til Skifteretten i Aarhus om opløsning af virksomheden, er tilbagetaget.
Direktion:
Tiltrådte:
Orla Møller Petersen, den 08.02.2017.
Virksomheden tegnes af en direktør.
Anmodning om opløsning, jf. selskabslovens § 225 sendt til Skifteretten i Aarhus den 14.01.2017
Direktion:
Fratrådte:
Orla Møller Petersen (adm. dir), den 14.01.2017.
Direktion:
Fratrådte:
Steen Borregaard (adm. dir), den 01.12.2015.
Tiltrådte:
Orla Møller Petersen (adm. dir), den 01.12.2015.
CVR-nummer:
36983922.
NAVN:
Saponin Innovation Centre Europe IVS.
Adresse: c/o Agro Business Park A/S, Niels Pedersens Alle 2, 8830 Tjele.
Kommune: Viborg.
Ny adresse: c/o Agro Business Park A/S, Agro Food Park 13, 8200 Aarhus N
Ny kommune: Århus
CVR-nummer:
36983922.
NAVN:
Saponin Innovation Centre Europe IVS.
Adresse: c/o Agro Business Park A/S, Niels Pedersens Alle 2, 8830 Tjele.
Kommune: Viborg.
Binavne: SICE IVS.
Stiftelsesdato: 01.08.2015.
Virkningsdato: 01.08.2015.
Seneste vedtægtsdato: 01.08.2015.
Kapital:
kr. 1.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 1.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 21500445 BORREGAARD BIOPLANT ApS, Helsingforsgade 27B, 8200 Aarhus N, den 01.08.2015.
Direktion:
Steen Borregaard (adm. dir), den 01.08.2015.
Virksomheden tegnes af en direktør alene..
Første regnskabsår:
01.08.2015 - 30.06.2016.
Regnskabsår:
01.07 - 30.06.
Formål:
Virksomhedens formål er at udøve konsulentbistand, forskning, handel, udvikling og anden erhvervsvirksomhed med relation til råvarer, produkter og anvendelser af stoffet saponin eller andre stoffer der indeholder saponin, med fokus på kommerciel udnyttelse af saponin i kommerciel henseende.
P-number 1020632220Agro Food Park 13, 8200 Aarhus N